Cargando…
A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840824/ https://www.ncbi.nlm.nih.gov/pubmed/35167905 http://dx.doi.org/10.1016/j.anai.2022.02.004 |
| _version_ | 1784650711445798912 |
|---|---|
| author | Sarkaria, Sandeep Kalkat, Amanpreet Hostoffer, Robert |
| author_facet | Sarkaria, Sandeep Kalkat, Amanpreet Hostoffer, Robert |
| author_sort | Sarkaria, Sandeep |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8840824 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88408242022-02-14 A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection Sarkaria, Sandeep Kalkat, Amanpreet Hostoffer, Robert Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-04 2022-02-12 /pmc/articles/PMC8840824/ /pubmed/35167905 http://dx.doi.org/10.1016/j.anai.2022.02.004 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters Sarkaria, Sandeep Kalkat, Amanpreet Hostoffer, Robert A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title | A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title_full | A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title_fullStr | A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title_full_unstemmed | A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title_short | A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| title_sort | coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840824/ https://www.ncbi.nlm.nih.gov/pubmed/35167905 http://dx.doi.org/10.1016/j.anai.2022.02.004 |
| work_keys_str_mv | AT sarkariasandeep acoronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection AT kalkatamanpreet acoronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection AT hostofferrobert acoronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection AT sarkariasandeep coronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection AT kalkatamanpreet coronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection AT hostofferrobert coronavirusdisease2019vaccinatedpatientwithphosphoinositide3kinasediseasewithmildillnessaftersevereacuterespiratorysyndromecoronavirus2infection |